CompoAtlas

CiCal D

Natural health product licensed in Canada

Licence holder
Euro-Pharm International Canada Inc.
NPN or DIN-HM
80003806
Status
Inactive licence
Licence date
30 July 2007
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal composition not provided.

Non-medicinal ingredients

Béhénate de glycéryle, Quinoline Yellow WS, Dioxyde de silicium colloïdal, Croscarmellose de sodium, Acide citrique anhydre

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Comprimé2 Tous les jours

Uses authorised in Canada

Helps in the normal development and maintenance of bones and teeth. Helps to prevent bone resorption and osteoporosis. A factor in the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80003806

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line